Objective Cytomegalovirus (CMV) infection can cause severe morbidity and mortality in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT). Letermovir is recommended as CMV prophylaxis for allo-HSCT recipients. This study aimed to further confirm the efficacy of letermovir prophylaxis in d...
Yi Xia, Qi Wen, Jing Liu et al.· Frontiers in Immunology· 0 citations
OBJECTIVES
EBV reactivation after allogeneic hematopoietic stem cell transplantation (allo-HSCT) is typically monitored by plasma viral load, but this fails to capture cellular reservoirs. Lineage-specific testing, though usually performed in high-risk patients, may identify biologically distinct disease states. We aim...
Zhi-Fan Zhao, Zhuo-Jun Liu, Qiang Huang et al.· Clinical Microbiology and In...· 0 citations
Thymus-dependent de novo T-cell generation is essential for maintaining T-cell diversity and immune competence. Although thymic involution after puberty reduces thymic output, residual thymic function remains important for immune surveillance and immune reconstitution following hematopoietic stem cell transplantation (...
Fangqing Zhang, Xinya Jiang, Shuang Fan et al.· Experimental Hematology & On...· 0 citations
BACKGROUND
High-dose cyclophosphamide (Cy)-related cardiotoxicity (CT) during transplant conditioning in patients with severe aplastic anemia (SAA) is a life-threatening complication.
OBJECTIVE
To evaluate the efficacy and safety of a modified conditioning regimen to reduce CT in pediatric SAA.
METHODS
We conducted...
Feng Zhang, P. Suo, Guan-Hua Hu et al.· Transplantation and Cellular...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.